For help locating resources, using the library, or to request a research consultation, try our Ask Us service.
Databases
Ovid’s Evidence Based Medicine Reviews includes the Cochrane Library as well as ACP Journal Club. The Cochrane Library is a collection of high-quality, independent evidence to inform healthcare decision-making.
EBM Reviews - Cochrane Central Register of Controlled Trials
Cochrane Central Register of Controlled Trials is a bibliographic database of definitive controlled trials, and part of Ovid's EBM Reviews collection. It contains over 300,000 bibliographic references to controlled trials in health care together with references to clinical trials identified by contributors to the Cochrane Collaboration in MEDLINE and EMBASE. Contributors follow quality control standards to ensure that only reports of definite randomized controlled trials or controlled clinical trials are included. These controlled trials included were identified by the contributors to the Cochrane Collaboration to create an unbiased source of data for systematic reviews.
The Cochrane Database of Systematic Reviews is part of Ovid's EBM Reviews collection, and includes the full text of the regularly updated systematic reviews of the effects of healthcare prepared by The Cochrane Collaboration.
Ask Us
Ask Us
New / Trial E-resources
- Informit Indigenous Collection offers broad scope for critical international engagement with topical and historical issues paramount to understanding Indigenous studies across the world.
Trial runs through December 16, 2023. Please submit your feedback using the Trial E-resource Feedback Form. - Canada Commons is an updated version of the Canadian Electronic Library. It features Canadian ebooks, public policy papers, and a directory of Canadian research and government organizations.
This trial runs through Nov. 22, 2023. Please submit feedback using the Trial E-resource Feedback Form. - Scite.ai is a discovery and evaluation platform which analyzes how and where a citation was used within a publication.
Trial runs through November 30, 2023. Please submit feedback using the Trial E-resource Feedback Form.